ICON plc delivered solid third-quarter results amidst an uncertain market, achieving $2,042.8 million in revenue and $2.4 million in GAAP net income. The company reported strong gross business wins and a net book-to-bill ratio of 1.02, but faced challenges including delayed decision-making and elevated cancellations. Adjusted EBITDA was $396.7 million, and the company repurchased $250.0 million worth of stock.

ICON plc delivered solid performance in Q2 2025, with significant growth in gross business wins and a healthy net book-to-bill ratio. While revenue saw a slight decrease year-over-year, net income and adjusted EBITDA remained strong, reflecting effective cost management and strategic share repurchases. The company also updated its full-year 2025 financial guidance, raising the midpoint for revenue and maintaining adjusted diluted EPS expectations.

ICON plc reported a challenging first quarter of 2025 with revenue and bookings below expectations due to market volatility and delays in customer decision making. Despite revenue pressure, adjusted EBITDA margin and EPS were in line with expectations due to cost control. Full-year 2025 guidance was updated, primarily excluding two large next-generation COVID vaccine trials.

ICON reported Q4 2024 revenue of $2.04 billion, a 1.2% decrease from the prior year. Net income increased to $260 million, and adjusted EPS reached $3.43. The company also reported strong free cash flow and reaffirmed its full-year 2025 financial guidance.